EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The emerging role of USP29 in cancer and other diseases

Ru Zhang, Zeqiong Cai, Doudou Ren, Ye Kang, Qi Zhang, Xinlan Lu, Rongfu Tu

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.3928 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Function, 2024. Verfasst von Ru Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reversible protein ubiquitination is a key process for maintaining cellular homeostasis. Deubiquitinases, which can cleave ubiquitin from substrate proteins, have been reported to be deeply involved in disease progression ranging from oncology to neurological diseases. The human genome encodes approximately 100 deubiquitinases, most of which are poorly characterized. One of the well‐characterized deubiquitases is ubiquitin‐specific protease 29 (USP29), which is often upregulated in pathological tissues and plays important roles in the progression of different diseases. Moreover, several studies have shown that deletion of Usp29 in mice does not cause visible growth and developmental defects, indicating that USP29 may be an ideal therapeutic target. In this review, we provide a comprehensive summary of the important roles and regulatory mechanisms of USP29 in cancer and other diseases, which may help us better understand its biological functions and improve future studies to construct suitable USP29‐targeted therapy systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansAnimalsMiceGenome, HumanUbiquitinUbiquitinationDeubiquitinating EnzymesUbiquitin-Specific Proteases

Stichwörter der Autor:innen

USP29cancerdeubiquitinationprotein stabilitytarget therapy

Substanzen

UbiquitinDeubiquitinating EnzymesUSP29 protein, humanUbiquitin-Specific ProteasesUsp29 protein, mouse

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Cancer Precision Medicine, The MED-X Institute, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, R., Cai, Z., Ren, D., Kang, Y., Zhang, Q., Lu, X., & Tu, R. (2024). The emerging role of USP29 in cancer and other diseases. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3928

Vancouver

Zhang R, Cai Z, Ren D, Kang Y, Zhang Q, Lu X, et al. The emerging role of USP29 in cancer and other diseases. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3928

BibTeX
@article{Zhang2024,
  author = {Zhang, Ru and Cai, Zeqiong and Ren, Doudou and Kang, Ye and Zhang, Qi and Lu, Xinlan and Tu, Rongfu},
  title = {The emerging role of USP29 in cancer and other diseases},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.3928}
}
Kostenlos starten →